Meet Dr. John Tu

Dr. John H. Tu is the medical director at Dermatology Associates of Rochester and is a board-certified dermatologist. At our Rochester, NY, clinical research facility, Dr. Tu serves as principal investigator for Skin Search. He is certified by the American Board of Dermatology in general, medical, and surgical dermatology and is a fellow of the American Academy of Dermatology. Before joining Dermatology Associates, Dr. Tu served on the faculty at the University of Rochester School of Medicine and Dentistry at Strong Memorial Hospital. He is currently an attending dermatologist at Rochester General Hospital. In addition to specialty training in dermatology, he holds master’s degrees in both microbiology/immunology and optics.

Dr. Tu’s medical interests include the use of lasers and other light-based modalities to treat and diagnose skin disorders, medical and surgical methods to treat skin cancer, and diagnosis and management of disorders involving skin of color. He specializes in the use of fillers, BOTOX® Cosmetic and lasers to rejuvenate and enhance the appearance of diseased and sun-damaged skin.

If you’d like to meet with Dr. Tu or one of our other providers, request a consultation using the online form or call our office at (585) 272-0700 to schedule an appointment.

Cosmetic Dermatology Team

Specializing in Concierge Treatment Designed for You

We established Dermatology Associates of Rochester to provide quality, compassionate medical and cosmetic skin care in a boutique setting where patients felt like part of an extended family. Our board-certified dermatologists, nurse practitioners, and registered nurses work together with our professional staff to ensure you enjoy an exceptional experience each time you visit.

Meet the Dermatology Team

Clinical Specialties & Interests

Cosmetic Dermatology (Aesthetics & Anti-Aging):  Laser and light-based diagnostics and therapeutics

General Dermatology:  Ethnic skin, Computer vision based dermatologic diagnostics

Board Certifications

  • American Board of Dermatology
    Dermatology, 2009 (Re-Certification, Current)
    Dermatology, 1998 (Original Certificate)

Licensures

  • NY State Medical License
    NY license #220699
    2010-Current

Education & Training

  • University of Rochester
    Master of Science (MS), Optics, 2007
    Rochester, NY
  • University of Rochester
    Wilmot Cancer Research Fellow, 2002-2005
    Rochester, NY
  • University of Rochester
    Research Fellow, Body Imaging Laboratory, 2000-2002
    Rochester, NY
  • Massachusetts General Hospital – Harvard Department of Dermatology
    Research Fellow, Wellman Laboratories of Photomedicine, 1998-2000
    Boston, MA
  • Washington University Medical Center
    Resident in Dermatology, Barnes Jewish Hospital, 1995-1997
    St. Louis, MO
  • University of California, Los Angeles
    Internship, Internal Medicine, 1994-1995
    Los Angeles, CA
  • Albert Einstein College of Medicine
    Medical Doctor (MD), 1994
    Bronx, NY
  • Albert Einstein College of Medicine
    Master of Science (MS), Microbiology and Immunology, 1987
    Bronx, NY
  • The Johns Hopkins University
    Bachelor of Arts (BA), Biology and Molecular Biology, 1983
    Baltimore, MD

Investigational Studies

  • Effects of taxol on in­vitro 3T3 cell cycle progression, Laboratory of Robert W. Tucker, M.D., Cancer Research Center, The Johns Hopkins Medical Institutions, Baltimore, MD., 1982­ – 1983
  • Anti­mouse antibody titers in renal transplant patients on OKT3 immunoprophylaxis, Laboratory of William J. Smith, Ph.D., Division of Transplantation, Department of Surgery, The Johns Hopkins Medical Institutions, Baltimore, MD., 1983
  • Purification and characterization of an interleukin­1 inhibitor found in the urine of febrile patients (human DNase), Laboratory of David L. Rosenstreich, M.D., Division of Allergy and Immunology, Department of Medicine, Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY., 1985­ – 1987
  • Purification and characterization of an interleukin­2 inhibitor associated with pregnancy, Laboratory of David L. Rosenstreich, M.D., Division of Allergy and Immunology, Department of Medicine, Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY., 1987­ – 1992
  • Molecular biology of RU486, University of Paris Academic Exchange Program, Laboratory of Dr. Etienne­Emile Baulieu, Universite de Paris, Le Kremlin­Bicetre, Paris, France., Spring 1994
  • Gross and microscopic autofluorescence imaging of non­melanoma skin cancers, Laboratory of Nikiforos Kollias, Ph.D., and R. Rox Anderson, M.D., Wellman Laboratories of Photomedicine, Department of Dermatology, Massachusetts General Hospital, Boston, MA., 1998­ – 2000
  • Application of non­invasive autofluorescence imaging to diagnosis of non­melanoma skin cancers, Body Imaging Laboratory, Department of Dermatology, University of Rochester School of Medicine and Dentistry, Rochester, NY., 2000­
  • Phase III clinical trial: celecoxib chemoprevention of actinic keratosis. Department of Dermatology, University of Rochester School of Medicine and Dentistry, Rochester, NY., 2004­ – 2005
  • Wilmot Cancer Fellow, University of Rochester Medical Center, Rochester, NY., 2002­ – 2005
  • Phase IIA Actinic Keratosis, 2008, 2013, 2014
  • Phase II Acne, 2008, 2010, 2014
  • Phase III Acne, 2008­2014
  • Phase III Moderate to severe plaque psoriasis, 2008, 2009, 2010, 2012, 2013, 2014
  • Phase II Moderate to severe acne with nodules, 2008
  • Phase IV Moderate to severe plaque psoriasis of the scalp, 2008
  • Phase III Bioequivalent Topical Double Blind Acne, 2008, 2009, 2010, 2011, 2012, 2013
  • Phase IV Open Label Oral Acne, 2008
  • Phase III Double-Blind Oral Acne, 2008, 2012
  • Phase II Basal Cell Carcinoma, 2008 – ­2010
  • 13 Phase III Moderate­Severe Psoriasis trials with biologics, 2008­ – 2014
  • Phase II Severe Acne (Oral), 2008
  • Phase III Mild­Moderate topical acne, 2008­ – 2010
  • Phase III Mild­Moderate Psoriasis, 2008 – ­2010
  • Phase III Small Pox Vaccine Trial, 2008
  • Phase III Four Distal Onychomycosis Trial, 2009 – ­2013
  • Two Phase III Tinea Pedis Trial, 2010, 2013
  • Eleven Phase III Moderate to Severe Psoriasis Biologic Trials, 2010­ – 2013
  • Seven Bioequivalent Acne trials, 2009 – ­2014
  • Eleven Bioequivalent Actinic Keratosis trials, 2008­ – 2014

Publications

Rodriguez­ Burford, C., Mercurio, M., Tu, J.H., Carey, D., Han, R., Gordon, G., Niwas S., Bell, W., Elmets, C.A., Grizzle, W., Pentland, A.P.Selective COX­2 inhibition produces heterogeneous erythema response to UV-irradiation. J Invest Dermat. 125(6): 1317­20, 2005.

Brancaleon, L., Durkin, A.J., Tu, J.H., Menaker, G., Fallon, J.D., Kollias, N. In vivo fluorescence spectroscopy of nonmelanoma skin cancer. Photochem Photobiol 2001; 73(2):178­183.

Tu, J.H. and Eisen, A.Z., Scleroderma, in Fitzpatrick’s Dermatology in General Medicine. et al., Eds., New York, McGraw Hill, pp. 2023­-2033.

Tu, J.H., Mann, C., and Breer, W. Acute onset of dermal nodules in a patient with multiple myeloma on chemotherapy. Mini­Consults in Dermatology. Volume V. CD­ROM. From Gross and Microscopic Symposium. 1998 American Academy of Dermatology Annual Meeting. Orlando, FL.

Rosenstreich, D.L., Tu, J.H., Kinkade, P.R., Maurer­Fogy, I., Kahn, J., Barton, R. W., and Farina, P.R. 1987. A human urine­derived interleukin­1 inhibitor: Homology with deoxyribonuclease I. J Exp Med 168:1767­1779.

Rosenstreich, D.L., Yost, S.L., Brown, K.M., and Tu, J.H. 1987. Interleukins and interleukin inhibitors. Einstein Quart J. Biol Med 34:45­55.

Liao, Z., Tu, J.H., Small, C.B., Schnipper, S.M., and Rosenstreich, D.L. 1993. Increased urine interleukin­1levels in aging. Gerontol 39:19­2

Presentations

Invited Lecturer, British Society for Dermatologic Surgery, 2015 Annual Cutaneous Surgery Workshop, Edinburgh, UK, April 2015, “Drawing and Design in Cutaneous Surgery,” “Dermatology Across the Pond: Enlightening or Frightening.”

Invited Lecturer, British Society for Dermatologic Surgery, 2014 Annual Cutaneous Surgery Workshop, Birmingham, UK, April 2014, “The Fusiform Excision and Its Variants,” “10 Tips in 10 Minutes.”

Tu, J.H., Brancaleon, L., Menaker, G.M., Durkin, A.J., and Kollias, N. Use of Autofluorescence in Diagnosis and Management of Nonmelanoma Skin Cancer. Residents and Fellows Symposium. 2000 American Academy of Dermatology Annual Meeting, San Francisco, CA.

Tu, J.H., Mann, C., and Breer, W. Acute onset of dermal nodules in a patient with multiple myeloma on chemotherapy. Gross and Microscopic Symposium. 1998 American Academy of Dermatology Annual Meeting, Orlando, FL.

Professional Memberships

  • American Academy of Dermatology – AAD
    Member/FAAD
  • American Society for Dermatological Surgery – ASDS
    Member
  • American Society for Investigative Dermatology
    Member
  • European Academy of Dermatology and Venereology
    Member
  • American Society for Laser Medicine & Surgery – ASLMS
    Member
  • Medical Society of the State of New York
    Member

Hospital Affiliations

  • UR Medicine – Strong Memorial Hospital
    Rochester, NY
  • Highland Hospital
    Rochester, NY
  • Rochester Regional Health System
    Rochester, NY
    Clifton Springs, NY

Sign Up to Receive Our Newsletter

Back to Top